| ORZIPTA BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1539059 10 Aug 2011 | on 30 Aug 2017 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical antibodies for the treatment of the respiratory system; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | | ORZIPTA BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1276571 20 Oct 2005 | on 09 Nov 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical antibodies for the treatment of the respiratory system; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | 
